LRRK2 and Parkinson disease: First, patients should be counselled that the frequency of mutations is greatly determined by ethnic group; for example, we showed that the common LRRK2 Gly2019Ser mutation is found in 10% of Ashkenazi Jews with sporadic PD and in 4% of Portuguese patients with sporadic PD but in only 1% of white North Americans.